Xenon Pharmaceuticals (STU:XP0) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:XP0 Xenon Pharmaceuticals Inc STU:XP0
27 GF Score
Price €55.50
GF Value €0.14
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Xenon Pharmaceuticals Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:XP0
27GF Score
Xenon Pharmaceuticals Inc STU:XP0
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Xenon Pharmaceuticals (STU:XP0) Overvalued in 2026?

Based on GuruFocus' analysis, Xenon Pharmaceuticals stock appears to be overvalued. The current stock price of €55.50 is trading 39542.9% above its estimated GF Value™ of €0.14. GuruFocus considers Xenon Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for STU:XP0:

  • Short Ratio:
  • GF Value™: €0.14 vs. price of €55.50 (39542.9% above fair value)
  • GF Score™: 27/100 with 5 warning signs

No single metric tells the full story. See the STU:XP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xenon Pharmaceuticals Business Description

Other Exchanges XENE:USA
Address 200-3650 Gilmore Way, Burnaby, BC, CAN, V5G 4W8
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
27GF Score

Get the complete analysis for STU:XP0

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.50
Price
€0.14
GF Value